PHARMACEUTICAL CARE FOR PATIENTS OF UNIFIED HEALTH SYSTEM WITH SEVERE ACNE: A HEALTH SERVICE IN ACADEMIC ENVIROMENT

Abstract

Acne is a cutaneous, genetic-hormonal disease that causes the formation of comedones, papules, and pustules in the region of the face and thorax. The present study evaluated the impact of Pharmaceutical Care on patients of Unified Health System, receiving free isotretinoin for the treatment of severe acne in a health service developed in a public university pharmacy inserted in the Specialized Component of Pharmaceutical Care. A descriptive, retrospective and quantitative study was carried out, based on the analysis of the pharmacotherapeutic follow-up records, pharmaceutical interventions and laboratory tests documented in internal records of patients assisted by the Pharmacy School of the Federal University of Piauí from November 2015 to July 2017. The records of 23 patients in which 34 types of adverse drug reactions were detected, besides four pharmaceutical interventions, predominantly related to the risk of drug interactions. The results highlight the notoriety of the initiative to implant this type of service in an
academic locus for the training of new health professionals, in addition to the benefits of pharmaceutical follow-up for patients with severe acne.